RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Tofacitinib (selective Janus kinase inhibitor 1 and 3): a promising therapy for the treatment of alopecia areata: a case report of six patients

Tofacitinib (selective Janus kinase inhibitor 1 and 3): a promising therapy for the treatment of alopecia areata: a case report of six patients

Add to Collection
Case Reports CB Shivanna, C Shenoy, RA Priya - International Journal of …, 2018 - ncbi.nlm.nih.gov

Chapter : Section2
Journal Year : 2018
Cited by : 37

… Our patients are currently in follow-up and one among them is under remission … remission.[12,15] This is the first published case series of successful treatment with tofacitinib from …..... Read More

Keywords : ['tofacitinib selective janus kinase inhibitor', 'six patient', 'promising therapy', 'case report', 'alopecia areata', 'treatment']
PubMed Link : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028993/
Google Scholar Link : https://scholar.google.com/scholar?cites=4248886087770617733&as_sdt=5,33&sciodt=0,33&hl=en&num=20